E Briët
- Internal Medicine top 0.05%
- Venous Thromboembolism Diagnosis and Management 24
- Hematology top 0.05%
- Hemophilia Treatment and Research 63
- Blood Coagulation and Thrombosis Mechanisms 51
- Platelet Disorders and Treatments 25
-
- Atrial Fibrillation Management and Outcomes 11
- Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 12
- Obstetrics and Gynecology top 1%
-
- Cancer-related gene regulation 22
-
- Blood properties and coagulation 10
- Co-authors
- Suzanne C. CannegieterJan P. VandenbrouckeF.R. RosendaalF.J.M. van der MeerTed KosterFrits R. RosendaalR M BertinaF. R. Rosendaal
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
E Briët
132 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Internal Medicine 3.7k
- Hematology 5.5k
- Cardiology and Cardiovascular Medicine 4.4k
- Genetics 1.3k
- Obstetrics and Gynecology 431
Countries citing papers authored by E Briët
This map shows the geographic impact of E Briët's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Briët with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Briët more than expected).
Fields of papers citing papers by E Briët
This network shows the impact of papers produced by E Briët. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Briët. The network helps show where E Briët may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E Briët, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 1 | |
| 2 | 2011 | 40 | |
| 3 | ALLO-EXPOSED BLOOD DONORS AND TRANSFUSION-RELATED ACUTE LUNG INJURY | 2010 | 1 |
| 4 | [Pharmacotherapeutic choices for correction of disorders of primary hemostasis]. | 1999 | 1 |
| 5 | 1997 | 40 | |
| 6 | 1996 | 49 | |
| 7 | 1996 | 3 | |
| 8 | 1995 | 37 | |
| 9 | 1995 | 31 | |
| 10 | Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosisbreakdown → | 1995 | 873 |
| 11 | 1995 | 38 | |
| 12 | 1994 | 15 | |
| 13 | 1993 | 29 | |
| 14 | 1991 | 54 | |
| 15 | 1989 | 19 | |
| 16 | 1989 | 8 | |
| 17 | 1988 | 28 | |
| 18 | 1988 | 8 | |
| 19 | 1988 | 26 | |
| 20 | 1985 | 38 |
About E Briët
E Briët is a scholar working on Hematology, Internal Medicine and Genetics, having authored 136 papers that have together received 10.4k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (63 papers), Blood Coagulation and Thrombosis Mechanisms (51 papers), Platelet Disorders and Treatments (25 papers), Venous Thromboembolism Diagnosis and Management (24 papers), Cancer-related gene regulation (22 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (12 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Blood properties and coagulation (10 papers). The work is most often cited by research in Internal Medicine (3.7k citations), Hematology (5.5k citations) and Cardiology and Cardiovascular Medicine (4.4k citations). E Briët has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Suzanne C. Cannegieter, Jan P. Vandenbroucke, F.R. Rosendaal, F.J.M. van der Meer, Ted Koster, Frits R. Rosendaal, R M Bertina, F. R. Rosendaal, Andrew D. Blann and Hans de Ronde. Their work appears in journals such as Thrombosis and Haemostasis, Blood, The Lancet, British Journal of Haematology and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.